Century Therapeutics Inc (IPSC)
3.04
-0.03
(-0.98%)
USD |
NASDAQ |
May 09, 11:47
Century Therapeutics Price: 3.04 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 3.36 | 3.36 | 3.01 | 3.07 | 86653.00 |
May 07, 2024 | 3.17 | 3.70 | 3.12 | 3.37 | 113352.0 |
May 06, 2024 | 3.10 | 3.42 | 3.00 | 3.17 | 100162.0 |
May 03, 2024 | 3.10 | 3.20 | 2.98 | 3.03 | 187519.0 |
May 02, 2024 | 3.09 | 3.09 | 2.95 | 3.00 | 116137.0 |
May 01, 2024 | 2.96 | 3.13 | 2.96 | 3.04 | 109778.0 |
Apr 30, 2024 | 3.00 | 3.07 | 2.855 | 2.91 | 166629.0 |
Apr 29, 2024 | 2.88 | 3.450 | 2.88 | 3.05 | 102231.0 |
Apr 26, 2024 | 3.22 | 3.25 | 2.82 | 2.88 | 161095.0 |
Apr 25, 2024 | 2.88 | 3.18 | 2.85 | 3.15 | 116059.0 |
Apr 24, 2024 | 3.12 | 3.22 | 2.79 | 2.96 | 134089.0 |
Apr 23, 2024 | 3.09 | 3.565 | 2.96 | 3.13 | 75350.00 |
Apr 22, 2024 | 3.10 | 3.37 | 2.98 | 3.05 | 65688.00 |
Apr 19, 2024 | 2.99 | 3.20 | 2.905 | 3.09 | 112750.0 |
Apr 18, 2024 | 2.86 | 3.05 | 2.75 | 2.975 | 145448.0 |
Apr 17, 2024 | 3.21 | 3.215 | 2.82 | 2.84 | 179248.0 |
Apr 16, 2024 | 3.63 | 3.63 | 2.985 | 3.14 | 320558.0 |
Apr 15, 2024 | 3.92 | 3.99 | 3.625 | 3.67 | 42136.00 |
Apr 12, 2024 | 4.01 | 4.07 | 3.639 | 3.91 | 115200.0 |
Apr 11, 2024 | 3.97 | 4.428 | 3.800 | 4.05 | 248594.0 |
Apr 10, 2024 | 3.91 | 4.00 | 3.60 | 3.78 | 94887.00 |
Apr 09, 2024 | 3.72 | 4.05 | 3.68 | 4.01 | 79877.00 |
Apr 08, 2024 | 3.67 | 3.839 | 3.51 | 3.78 | 212083.0 |
Apr 05, 2024 | 3.63 | 3.75 | 3.57 | 3.63 | 27552.00 |
Apr 04, 2024 | 3.70 | 3.866 | 3.63 | 3.64 | 72538.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.28
Minimum
Nov 13 2023
31.93
Maximum
Aug 13 2021
9.576
Average
8.38
Median
Price Benchmarks
Verastem Inc | 11.91 |
First Wave BioPharma Inc | 2.81 |
Gritstone Bio Inc | 0.9523 |
Allogene Therapeutics Inc | 2.795 |
Mirum Pharmaceuticals Inc | 26.29 |
Price Related Metrics
PS Ratio | 80.69 |
PEG Ratio | -3.027 |
Price to Book Value | 1.067 |
Earnings Yield | -75.33% |
Market Cap | 197.05M |
PEGY Ratio | -3.027 |